ATE509097T1 - Gewinnung von rekombinantem menschlichem parainfluenzavirus typ 1 (hpivi) aus cdna - Google Patents
Gewinnung von rekombinantem menschlichem parainfluenzavirus typ 1 (hpivi) aus cdnaInfo
- Publication number
- ATE509097T1 ATE509097T1 AT02799195T AT02799195T ATE509097T1 AT E509097 T1 ATE509097 T1 AT E509097T1 AT 02799195 T AT02799195 T AT 02799195T AT 02799195 T AT02799195 T AT 02799195T AT E509097 T1 ATE509097 T1 AT E509097T1
- Authority
- AT
- Austria
- Prior art keywords
- hpivi
- recombinant human
- piv
- cdna
- recombinant
- Prior art date
Links
- 241000726041 Human respirovirus 1 Species 0.000 title 2
- 238000000917 particle-image velocimetry Methods 0.000 abstract 4
- 241000700605 Viruses Species 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 244000052769 pathogen Species 0.000 abstract 2
- 239000013598 vector Substances 0.000 abstract 2
- 208000002606 Paramyxoviridae Infections Diseases 0.000 abstract 1
- 230000002238 attenuated effect Effects 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002458 infectious effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18641—Use of virus, viral particle or viral elements as a vector
- C12N2760/18643—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18661—Methods of inactivation or attenuation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33196101P | 2001-11-21 | 2001-11-21 | |
| PCT/US2002/037688 WO2003043587A2 (en) | 2001-11-21 | 2002-11-21 | Recovery of recombinant human parainfluenza virus type 1 (hpivi) from cdna |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE509097T1 true ATE509097T1 (de) | 2011-05-15 |
Family
ID=23296092
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02799195T ATE509097T1 (de) | 2001-11-21 | 2002-11-21 | Gewinnung von rekombinantem menschlichem parainfluenzavirus typ 1 (hpivi) aus cdna |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7704509B2 (de) |
| EP (2) | EP2100955A3 (de) |
| AT (1) | ATE509097T1 (de) |
| AU (2) | AU2002364121C1 (de) |
| CA (1) | CA2467958A1 (de) |
| WO (1) | WO2003043587A2 (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050287540A1 (en) * | 1995-09-27 | 2005-12-29 | Murphy Brian R | Production of attenuated negative stranded RNA virus vaccines from cloned nucleotide sequences |
| KR101105984B1 (ko) | 2001-01-19 | 2012-01-18 | 비로노바티브 비.브이. | 감응성 포유류에서 호흡계 질환을 유발하는 바이러스 |
| US20030232061A1 (en) * | 2001-10-18 | 2003-12-18 | Fouchier Ronaldus Adrianus Maria | Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| US8715922B2 (en) * | 2001-01-19 | 2014-05-06 | ViroNovative | Virus causing respiratory tract illness in susceptible mammals |
| CA2743750A1 (en) | 2002-02-21 | 2003-09-04 | Medimmune, Llc | Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from respiratory syncytial virus |
| EP1572947B1 (de) * | 2002-09-18 | 2014-06-25 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | GEWINNUNG VON REKOMBINANTEM HUMANEM PARAINFLUENZA-VIRUS TYP 2 (HPIV2) AUS cDNA UND VERWENDUNG VON REKOMBINANTEM HPIV2 IN IMMUNOGENEN ZUSAMMENSETZUNGEN SOWIE ALS VEKTOREN ZUR HERVORRUFUNG VON IMMUNREAKTIONEN GEGEN PIV UND ANDERE MENSCHLICHE KRANKHEITSERREGER |
| EP1623006A4 (de) | 2003-04-25 | 2009-10-28 | Medimmune Vaccines Inc | Metapneumovirus-stämme und ihre verwendung in impfstofformulierungen und als vektoren zur expression antigener sequenzen sowie verfahren zur viruspropagierung |
| CN1813061B (zh) * | 2003-04-25 | 2013-05-29 | 免疫医疗有限责任公司 | 重组副流感病毒表达系统以及包含源自间质肺病毒的异种抗原的疫苗 |
| WO2006110214A2 (en) * | 2005-04-08 | 2006-10-19 | Medimmune, Inc. | Antibodies against mammalian metapneumovirus |
| US20070092871A1 (en) * | 2005-10-20 | 2007-04-26 | Combimatrix Corporation | Microarray for pathogen identification |
| US20100330120A1 (en) * | 2007-05-08 | 2010-12-30 | Collins Peter L | Human parainfluenza viruses having separated p and c genes |
| WO2009012155A2 (en) * | 2007-07-13 | 2009-01-22 | Medimmune, Llc | Preparation of negative-stranded rna viruses by electroporation |
| GB0719818D0 (en) | 2007-10-11 | 2007-11-21 | Asterion Ltd | Growth hormone fusion polypeptides |
| US20090186050A1 (en) * | 2007-11-16 | 2009-07-23 | Fouchier Ron A M | Live attenuated metapneumovirus strains and their use in vaccine formulations and chimeric metapneumovirus strains |
| US20110189232A1 (en) * | 2008-07-01 | 2011-08-04 | The Government Of The United States Of America Represented By The Secretary | RECOMBINANT HUMAN PARAINFLUENZA TYPE 1 VIRUSES (HPIV1s) CONTAINING MUTATIONS IN OR DELETION OF THE C PROTEIN ARE ATTENUATED IN AFRICAN GREEN MONKEYS AND IN CILIATED HUMAN AIRWAY EPITHELIAL CELLS AND ARE POTENTIAL VACCINE CANDIDATES FOR HPIV1 |
| LT2702159T (lt) | 2011-04-28 | 2019-01-10 | St. Jude Children`S Research Hospital | Modifikuoto sendai viruso vakcina ir iliustratyvus vektorius |
| WO2016118642A1 (en) * | 2015-01-20 | 2016-07-28 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Recombinant human/bovine parainfluenza virus 3 (b/hpiv3) expressing a chimeric rsv/bpiv3 f protein and uses thereof |
| CN116121206B (zh) * | 2022-10-13 | 2024-12-06 | 山东省农业科学院家禽研究所（山东省无特定病原鸡研究中心） | 一种ⅺ型新城疫病毒（f48e9）的重组拯救病毒制备方法、重组病毒及应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US708395A (en) | 1901-04-15 | 1902-09-02 | Oscar Peterson | Device for digging ditches. |
| US2177396A (en) | 1936-04-18 | 1939-10-24 | Borden Co | Milk bottle |
| DE3224404A1 (de) | 1982-06-30 | 1984-01-05 | LuK Lamellen und Kupplungsbau GmbH, 7580 Bühl | Reibungskupplung sowie verfahren zu deren montage |
| US4614197A (en) | 1984-10-15 | 1986-09-30 | Deere & Company | Chaff spreading arrangement for a combine |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4763497A (en) | 1986-09-03 | 1988-08-16 | Clover Co., Ltd. | Lock device for double sliding doors |
| US5938597A (en) | 1995-05-04 | 1999-08-17 | Stratbucker; Robert A. | Electrocardiograph bioelectric interface system and method of use |
| ATE181112T1 (de) | 1995-08-09 | 1999-06-15 | Schweiz Serum & Impfinst | Dem genom von minussträngigen rna-viren entsprechende cdna und verfahren zur herstellung von infektiösen minussträngigen rna-viren |
| ATE451451T1 (de) | 1996-07-15 | 2009-12-15 | Us Gov Health & Human Serv | Herstellung von attenuierten respiratorischen syncytialvirus-impfstoffen aus klonierten nukleotidsequenzen |
| US6699476B1 (en) | 1996-07-15 | 2004-03-02 | Peter L. Collins | Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules |
| CN1250725C (zh) | 1997-05-23 | 2006-04-12 | 美国政府健康及人类服务部 | 从克隆的核苷酸序列制备减毒副流感病毒疫苗的方法 |
| US6410023B1 (en) | 1997-05-23 | 2002-06-25 | United States Of America | Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of a non-essential gene |
| CN101392239A (zh) | 1999-07-09 | 2009-03-25 | 美国政府健康及人类服务部 | 减毒的人-牛嵌合副流感病毒(piv)疫苗 |
| CN102766605A (zh) | 1999-12-10 | 2012-11-07 | 由卫生与公众服务部代表的美利坚合众国政府 | 重组副流感病毒(piv)作为载体提供保护对抗piv及其他人类病原体引起的感染和疾病的用途 |
| US8379398B2 (en) | 2011-03-23 | 2013-02-19 | Phoenix Contact Development & Manufacturing, Inc. | DIN rail mountable base for process fieldbus redundant power conditioner |
-
2002
- 2002-11-21 AT AT02799195T patent/ATE509097T1/de not_active IP Right Cessation
- 2002-11-21 AU AU2002364121A patent/AU2002364121C1/en not_active Ceased
- 2002-11-21 CA CA002467958A patent/CA2467958A1/en not_active Abandoned
- 2002-11-21 WO PCT/US2002/037688 patent/WO2003043587A2/en not_active Ceased
- 2002-11-21 US US10/302,547 patent/US7704509B2/en not_active Expired - Lifetime
- 2002-11-21 EP EP09162824A patent/EP2100955A3/de not_active Withdrawn
- 2002-11-21 EP EP02799195A patent/EP1456398B1/de not_active Expired - Lifetime
-
2009
- 2009-06-12 AU AU2009202359A patent/AU2009202359A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003043587A9 (en) | 2011-06-09 |
| EP1456398B1 (de) | 2011-05-11 |
| WO2003043587A3 (en) | 2004-04-22 |
| US7704509B2 (en) | 2010-04-27 |
| EP1456398A4 (de) | 2006-09-27 |
| EP2100955A3 (de) | 2009-12-02 |
| EP1456398A2 (de) | 2004-09-15 |
| CA2467958A1 (en) | 2003-05-30 |
| AU2002364121C1 (en) | 2010-02-18 |
| AU2009202359A1 (en) | 2009-07-02 |
| WO2003043587A2 (en) | 2003-05-30 |
| AU2002364121B2 (en) | 2009-03-12 |
| AU2002364121A1 (en) | 2003-06-10 |
| EP2100955A2 (de) | 2009-09-16 |
| US20040142448A1 (en) | 2004-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE509097T1 (de) | Gewinnung von rekombinantem menschlichem parainfluenzavirus typ 1 (hpivi) aus cdna | |
| WO2004027037A3 (en) | RECOVERY OF RECOMBINANT HUMAN PARAINFLUENZA VIRUS TYPE 2 (HPIV2) FROM cDNA AND USE OF RECOMBINANT HPIV2 IN IMMUNOGENIC COMPOSITIONS AND AS VECTORS TO ELICIT IMMUNE RESPONSES AGAINST PIV AND OTHER HUMAN PATHOGENS | |
| WO2005014626A3 (en) | Recombinant human metapneumovirus and its use | |
| ATE408693T1 (de) | Attenuiertes human-bovines chimärisches parainfluenzavirus als impfstoff | |
| EP1326633A4 (de) | Zusammensetzung mit immunogenen mikroteilchen | |
| DE60139963D1 (de) | Fusionsproteine aus mycobakterium tuberculosis | |
| DE60130569D1 (de) | Verpackung von replikon-partikeln eines positiv-strängigen rna-virus | |
| WO2003048184A3 (en) | Flavivirus ns1 subunit vaccine | |
| ATE364624T1 (de) | Multisystemisches kümmerwuchssyndrom durch viren in schweine | |
| ATE417097T1 (de) | Rekombinantes respiratorische synzytialvirus expressionssystem und impfstoffe | |
| EP2263690A3 (de) | Chimäre infektiöse DNS-Klone von Schweine-Circoviren und ihre Verwendung | |
| EE200300173A (et) | Vaktsiiniaviirus, selle valmistamine ja kasutamine, seda sisaldav farmatseutiline kompositsioon ja vaktsiin ning meetod immuunreaktsiooni mõjutamiseks | |
| ATE388230T1 (de) | Neisseria meningitidis antigene und zusammenstellungen | |
| BR0312173A (pt) | Mólecula de cdna, molécula e sequência de cdna recombinante, vetor, processo de preparação de partìculas de vìrus do sarampo infeccioso, composição imunogênica, composição de vacina e vìrus mononegaviral recombinante | |
| ZA936629B (en) | Potentiation of immunogenic response | |
| TW200602495A (en) | Synergistic attenutation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof | |
| EP1399163A4 (de) | Verbindungen, verfahren und zusammensetzungen für die behandlung von infektionen mit dem rinderdiarrhö-virus (bvdv) und dem hepatitis-c-virus (hcv) | |
| WO2004085633A8 (en) | A novel human virus causing severe acute respiratory syndrome (sars) and uses thereof | |
| WO2003076591A8 (en) | Compositions and methods for generating an immune response | |
| WO2008048984A3 (en) | Methods and compositions for preparing a universal influenza vaccine | |
| WO2009051823A3 (en) | Bacterial artificial chromosome containing feline herpes virus type 1 genome and uses thereof | |
| EP1794329A4 (de) | Isolate des das reproduktions- und atemwegssyndrom verursachenden schweinevirus und ihre verwendung | |
| NO983946D0 (no) | Parapoksyviruser inneholdende fremmed DNA, fremstilling og anvendelse derav i vaksiner | |
| DE602004027362D1 (de) | Zusammensetzungen und verfahren mit dem respiratory syncytial virus untergruppe b stamm 9320 | |
| WO2002027007A3 (en) | Production of viral vectors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |